tRF-1:30-Gly-CCC-3 inhibits thyroid cancer via binding to PC and modulating metabolic reprogramming.

MLA

Fu, Bifei, et al. “TRF-1:30-Gly-CCC-3 Inhibits Thyroid Cancer via Binding to PC and Modulating Metabolic Reprogramming.” Life Science Alliance, vol. 7, no. 3, Dec. 2023. EBSCOhost, https://doi.org/10.26508/lsa.202302285.

APA

Fu, B., Lou, Y., Lu, X., Wu, Z., Ni, J., Jin, C., Wu, P., & Xu, C. (2023). tRF-1:30-Gly-CCC-3 inhibits thyroid cancer via binding to PC and modulating metabolic reprogramming. Life Science Alliance, 7(3). https://doi.org/10.26508/lsa.202302285

Chicago

Fu, Bifei, YuMing Lou, Xiaofeng Lu, Zhaolin Wu, Junjie Ni, Cong Jin, Pu Wu, and Chaoyang Xu. 2023. “TRF-1:30-Gly-CCC-3 Inhibits Thyroid Cancer via Binding to PC and Modulating Metabolic Reprogramming.” Life Science Alliance 7 (3). doi:10.26508/lsa.202302285.